18:43 IST
BSE
Management Change
Sudarshan Pharma Industries Management Change
Mr. Sachin Mehta resigned as Chief Financial Officer effective May 1, 2026. He will continue serving as the company's Joint Managing Director.
Sudarshan Pharma Industries Ltd
- Share price
- ₹38.91
- Market cap
- ₹936.4 Cr
- Revenue (annual)
- ₹703.1 Cr
- Net profit (annual)
- ₹23.30 Cr
- P/E (TTM)
- 40.2×Sector 36.8×
- Promoter holding
- 58.93%+1.54% QoQ
- FII holding
- 19.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Board Meeting Date 7Share Pledge 5Other Announcement 4Financial Results 4Annual General Meeting 4Management Change 3Capital Structure Change 3Merger & Restructuring 2Fund Raise 2Acquisition 2Results Correction 1Earnings Call 1Board Meeting Outcome 1Annual Report 1
Time
3 announcements with these filters
00:01 IST
BSE
Management Change
Sudarshan Pharma Industries Management Change
Mr. Sachin Mehta has resigned as Chief Financial Officer of Sudarshan Pharma Industries Ltd, effective May 1, 2026. He will continue to serve the company in his capacity as Joint Managing Director. This transition represents a focused leadership adjustment within the organization's senior management structure.
23:56 IST
BSE
Management Change
Sudarshan Pharma Industries Management Change
Sudarshan Pharma Industries Ltd appointed Mr. Sanat Bhat (Independent Director), Dr. Vinay Pandey (Non-Executive Director), and Mr. Sharad Govindrao Kathawate (CFO) effective May 1, 2026. These leadership changes bring expertise in finance, infrastructure, and geotechnical engineering to the board and management team.